Pro-med Technology
Latest round
- Series A
Last raised
- May 2017
Total raised
- Undisclosed
Investors
- 1
About Pro-med Technology
Established in 2013 and based in Beijing, China, Pro-med Technology is a reagent developer that provides colloidal gold quantitative reagent, fluorescent quantitative reagent, molecular diagnostic reagent and relevant devices or reagents. At present, the company has 8,000 square meters of production and development site, 1,000 square meters of GMP workshop, more than 30 core patents authorized, more than 80 product registration certificates, the products have been sold to more than 5,000 medical institutions in more than 30 provinces. The company's product line includes more than 60 detection reagents of health elements, pediatric infection, cardiovascular and cerebrovascular diseases, stomach health, and women's health. The company's clotting product line is represented by the CWPS thromboelastogram, which can provide a variety of detection reagents such as ordinary cup, heparinase cup, platelet aggregation, rapid coagulation and quality control products for different clinical situations. The company has also developed a series of molecular microfluidic detection reagents represented by the nine joint examination of respiratory pathogens and the twelve joint examination of respiratory pathogens. In the future, the company will focus on the development of coagulation product line, increase the company's R & D capital investment, and set up a coagulation R & D center in Suzhou.
Who invested in Pro-med Technology
1 investor across 1 round
See all investors in Pro-med Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 3, 2017
Amount
Undisclosed
Investors
Questions about Pro-med Technology
Who invested in Pro-med Technology?
Pro-med Technology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pro-med Technology raised?
Pro-med Technology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pro-med Technology last raise money?
Pro-med Technology's most recent round on record is a Series A, in May 2017.
What does Pro-med Technology do?
Established in 2013 and based in Beijing, China, Pro-med Technology is a reagent developer that provides colloidal gold quantitative reagent, fluorescent quantitative reagent, molecular diagnostic reagent and relevant devices or reagents.
Where is Pro-med Technology headquartered?
Pro-med Technology is headquartered in Beijing, China.
Which VCs invest in companies like Pro-med Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Pro-med Technology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Pro-med Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.